In vivo modulation of nitric oxide concentration dynamics upon glutamatergic neuronal activation in the hippocampus

Hippocampus

Volumn 21, Issue 6, 2011, Pages 622-630

  LourençO, Cátia F ^a,b   Santos, Ricardo ^a,b   Barbosa, Rui M ^a,b   Gerhardt, Greg ^c   Cadenas, Enrique ^d   Laranjinha, JoãO ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Concentration dynamics; Hippocampus; Ionotropic glutamate receptors; Microelectrodes; Nitric oxide

Indexed keywords

6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; DIZOCILPINE; GLUTAMIC ACID; IONOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID; NITRIC OXIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; DENTATE GYRUS; DOSE RESPONSE; ELECTROCHEMICAL ANALYSIS; HIPPOCAMPAL CA1 REGION; HIPPOCAMPUS; IN VIVO STUDY; MICROELECTRODE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS;

ANIMALS; CA1 REGION, HIPPOCAMPAL; DENTATE GYRUS; DIZOCILPINE MALEATE; ELECTROCHEMICAL TECHNIQUES; ENZYME INHIBITORS; EXCITATORY AMINO ACID ANTAGONISTS; GLUTAMIC ACID; MALE; MICROELECTRODES; N-METHYLASPARTATE; NEURONS; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; QUINOXALINES; RATS; RATS, WISTAR; RECEPTORS, AMPA; RECEPTORS, GLUTAMATE; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 79956360575     PISSN: 10509631     EISSN: 10981063     Source Type: Journal    
DOI: 10.1002/hipo.20774     Document Type: Article

References (39)

1. Babbedge RC, Bland-Ward PA, Hart SL, Moore PK. 1993. Inhibition of rat cerebellar nitric oxide synthase by 7-nitro indazole and related substituted indazoles. Br J Pharmacol 110: 225-228.
2. Barbosa RM, Lourenco CF, Santos RM, Pomerleau F, Huettl P, Gerhardt GA, Laranjinha J. 2008. In vivo real-time measurement of nitric oxide in anesthetized rat brain. Methods Enzymol 441: 351-367.
3. Bhardwaj A, Northington FJ, Ichord RN, Hanley DF, Traystman RJ, Koehler RC. 1997. Characterization of ionotropic glutamate receptor-mediated nitric oxide production in vivo in rats. Stroke 28: 850-856; discussion 856-857.
4. Bredt DS, Snyder SH. 1989. Nitric oxide mediates glutamate-linked enhancement of cGMP levels in the cerebellum. Proc Natl Acad Sci USA 86: 9030-9033.
5. Brenman JE, Chao DS, Gee SH, McGee AW, Craven SE, Santillano DR, Wu Z, Huang F, Xia H, Peters MF, Froehner SC, Bredt DS. 1996. Interaction of nitric oxide synthase with the postsynaptic density protein PSD-95 and alpha1-syntrophin mediated by PDZ domains. Cell 84: 757-767.
6. Burmeister JJ, Pomerleau F, Palmer M, Day BK, Huettl P, Gerhardt GA. 2002. Improved ceramic-based multisite microelectrode for rapid measurements of L-glutamate in the CNS. J Neurosci Methods 119: 163-171.
7. Bush MA, Pollack GM. 2001. Pharmacokinetics and pharmacodynamics of 7-nitroindazole, a selective nitric oxide synthase inhibitor, in the rat hippocampus. Pharm Res 18: 1607-1612.
8. Crane BR, Arvai AS, Gachhui R, Wu C, Ghosh DK, Getzoff ED, Stuehr DJ, Tainer JA. 1997. The structure of nitric oxide synthase oxygenase domain and inhibitor complexes. Science 278: 425-431.
9. Danbolt NC. 2001. Glutamate uptake. Prog Neurobiol 65: 1-105.
10. Endoh M, Maiese K, Wagner JA. 1994. Expression of the neural form of nitric oxide synthase by CA1 hippocampal neurons and other central nervous system neurons. Neuroscience 63: 679-689.
11. Fekete A, Vizi ES, Kovacs KJ, Lendvai B, Zelles T. 2008. Layer-specific differences in reactive oxygen species levels after oxygen-glucose deprivation in acute hippocampal slices. Free Radic Biol Med 44: 1010-1022.
12. Frade JG, Barbosa RM, Laranjinha J. 2008. Stimulation of NMDA and AMPA glutamate receptors elicits distinct concentration dynamics of nitric oxide in rat hippocampal slices. Hippocampus 603-611.
13. Friedemann MN, Gerhardt GA. 1996. In vivo electrochemical studiesof the dynamic effects of locally applied excitatory amino acids in the striatum of the anesthetized rat. Exp Neurol 138: 53-63.
14. Garthwaite J, Charles SL, Chess-Williams R. 1988. Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in the brain. Nature 336: 385-388.
15. Hara MR, Snyder SH. 2007. Cell signaling and neuronal death. Annu Rev Pharmacol Toxicol 47: 117-141.
16. Kalisch BE, Connop BP, Jhamandas K, Beninger RJ, Boegman RJ. 1996. Differential action of 7-nitro indazole on rat brain nitric oxide synthase. Neurosci Lett 219: 75-78.
17. Kew JN, Kemp JA. 2005. Ionotropic and metabotropic glutamate receptor structure and pharmacology. Psychopharmacology (Berl) 179: 4-29.
18. Laranjinha J, Ledo A. 2007. Coordination of physiologic and toxic pathways in hippocampus by nitric oxide and mitochondria. Front Biosci 12: 1094-1106.
19. Ledo A, Barbosa RM, Gerhardt GA, Cadenas E, Laranjinha J. 2005. Concentration dynamics of nitric oxide in rat hippocampal subregions evoked by stimulation of the NMDA glutamate receptor. Proc Natl Acad Sci USA 102: 17483-17488.
20. Ledo A, Frade J, Barbosa RM, Laranjinha J. 2006. Regulation of nitric oxide dynamics in hippocampus by NMDA and AMPA glutamate receptors. Curr Top Pharmacol 10: 55-70.
21. Lehre KP, Danbolt NC. 1998. The number of glutamate transporter subtype molecules at glutamatergic synapses: Chemical and stereological quantification in young adult rat brain. J Neurosci 18: 8751-8757.
22. MacKenzie GM, Rose S, Bland-Ward PA, Moore PK, Jenner P, Marsden CD. 1994. Time course of inhibition of brain nitric oxide synthase by 7-nitro indazole. Neuroreport 5: 1993-1996.
23. Mayer B, Andrew P. 1998. Nitric oxide synthases: Catalytic function and progress towards selective inhibition. Naunyn Schmiedebergs Arch Pharmacol 358: 127-133.
24. Moncada S, Bolanos JP. 2006. Nitric oxide, cell bioenergetics and neurodegeneration. J Neurochem 97: 1676-1689.
25. Moore PK, Bland-Ward PA. 1996. 7-nitroindazole: An inhibitor of nitric oxide synthase. Methods Enzymol 268: 393-398.
26. Moore PK, Wallace P, Gaffen Z, Hart SL, Babbedge RC. 1993. Characterization of the novel nitric oxide synthase inhibitor 7-nitro indazole and related indazoles: Antinociceptive and cardiovascular effects. Br J Pharmacol 110: 219-224.
27. Pacher P, Beckman JS, Liaudet L. 2007. Nitric oxide and peroxynitrite in health and disease. Physiol Rev 87: 315-424.
28. Patneau DK, Mayer ML. 1990. Structure-activity relationships for amino acid transmitter candidates acting at N-methyl-D-aspartate and quisqualate receptors. J Neurosci 10: 2385-2399.
29. Paxinos C, Watson G. 2007. The rat brain in stereotaxic coordinates. Academic Press, New York.
30. Planells-Cases R, Montoliu C, Humet M, Fernandez AM, Garcia-Martinez C, Valera E, Merino JM, Perez-Paya E, Messeguer A, Felipo V, Ferrer-Montiel A. 2002. A novel N-methyl-D-aspartate receptor open channel blocker with in vivo neuroprotectant activity. J Pharmacol Exp Ther 302: 163-173.
31. Reiner A, Zagvazdin Y. 1998. On the selectivity of 7-nitroindazole as an inhibitor of neuronal nitric oxide synthase. Trends Pharmacol Sci 19: 348-350.
32. Santos RM, Lourenco CF, Piedade AP, Andrews R, Pomerleau F, Huettl P, Gerhardt GA, Laranjinha J, Barbosa RM. 2008. A comparative study of carbon fiber-based microelectrodes for the measurement of nitric oxide in brain tissue. Biosens Bioelectron 24: 704-709.
33. Sheardown MJ, Nielsen EO, Hansen AJ, Jacobsen P, Honore T. 1990. 2, 3-Dihydroxy-6-nitro-7-sulfamoyl-benzo(F)quinoxaline: A neuroprotectant for cerebral ischemia. Science 247: 571-574.
34. Vezzani A, Serafini R, Stasi MA, Caccia S, Conti I, Tridico RV, Samanin R. 1989. Kinetics of MK-801 and its effect on quinolinic acid-induced seizures and neurotoxicity in rats. J Pharmacol Exp Ther 249: 278-283.
35. Volke V, Soosaar A, Koks S, Bourin M, Mannisto PT, Vasar E. 1997. 7-Nitroindazole, a nitric oxide synthase inhibitor, has anxiolytic-like properties in exploratory models of anxiety. Psychopharmacology (Berl) 131: 399-405.
36. Vornov JJ, Tasker RC, Coyle JT. 1991. Direct observation of the agonist-specific regional vulnerability to glutamate, NMDA, and kainate neurotoxicity in organotypic hippocampal cultures. Exp Neurol 114: 11-22.
37. Wennmalm A, Lanne B, Petersson AS. 1990. Detection of endothelial-derived relaxing factor in human plasma in the basal state and following ischemia using electron paramagnetic resonance spectrometry. Anal Biochem 187: 359-363.
38. Xia J, Zhang X, Staudinger J, Huganir RL. 1999. Clustering of AMPA receptors by the synaptic PDZ domain-containing protein PICK1. Neuron 22: 179-187.
39. Zhong WX, Dong ZF, Tian M, Cao J, Xu L. 2006. N-methyl-D-aspartate receptor-dependent long-term potentiation in CA1 region affects synaptic expression of glutamate receptor subunits and associated proteins in the whole hippocampus. Neuroscience 141: 1399- 1413.